Analyst firms · Raymond James · HUM
Raymond James HUM price target and rating history
Humana Inc. (HUM) · Health Care
Raymond James rates Humana Inc. (HUM) Outperform with a $520 price target, as of its latest action on Oct 12, 2026. It has published 4 rating actions on HUM since March 2024, including 2 upgrades and 1 downgrade. Across 13 firms with a HUM price target in the last 12 months, the median target is $500. Raymond James's $520 is 4% above that.
- Current rating
- Outperform
- Price target
- $520
- Median target, all firms
- $500
- Actions on HUM
- 4
Raymond James price target on HUM
Every Raymond James rating on HUM
- Oct 12, 2026
- Jul 30, 2026
- May 1, 2025
- Mar 22, 2024
How other firms rate HUM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| TD Cowen | Buy | $485 | Nov 20, 2026 |
| RBC Capital Markets | Outperform | $563 | Nov 16, 2026 |
| Raymond James | Outperform | $520 | Oct 12, 2026 |
| Robert W. Baird | Outperform | $596 | Oct 9, 2026 |
| Cantor Fitzgerald | Overweight | $460 | Oct 7, 2026 |
| Barclays | Overweight | $515 | Sep 25, 2026 |
| Morgan Stanley | Equal-Weight | $370 | Aug 5, 2026 |
| Evercore ISI | Outperform | $480 | Jul 30, 2026 |
| Leerink Partners | Outperform | $513 | Jul 30, 2026 |
| BofA Securities | Buy | $500 | Jul 29, 2026 |
| Wells Fargo | Overweight | $502 | Jul 13, 2026 |
| Deutsche Bank | Buy | $441 | May 20, 2026 |
| Jefferies | Buy | $313 | Dec 5, 2025 |
Questions about Raymond James and HUM
- What is Raymond James's price target for HUM?
- Raymond James's latest stated price target for Humana Inc. (HUM) is $520, from its action on Oct 12, 2026.
- What is Raymond James's rating on HUM?
- Raymond James rates HUM Outperform, a bullish rating, as of Oct 12, 2026.
- When did Raymond James last change its view on HUM?
- On Oct 12, 2026, Raymond James upgrades to Outperform from Mkt Perform, price target $520.
- How does Raymond James's HUM target compare with other analysts?
- Across 13 firms with a HUM price target in the last 12 months, the median target is $500. Raymond James's $520 is 4% above that.
More HUM rating histories
- TD Cowen3
- RBC Capital Markets3
- Cantor Fitzgerald3
- Barclays5
- Morgan Stanley10
- Leerink Partners5
- BofA Securities6
- Wells Fargo5
- Deutsche Bank4
- Goldman Sachs3
- Argus Research3
All Raymond James ratingsHUM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.